Cargando…
DIABRISK-SL trial: further consideration of age and impact of imputations
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide. Early interventions may help to delay or prevent onset of cardiometabolic endpoints of clinical importance to T2DM patients. Wijesuriya et al. (BMC Med 15:146, 2017) published results of a randomised controlled tr...
Autores principales: | Gkioni, Efstathia, Glonti, Ketevan, Dodd, Susanna, Gamble, Carrol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598268/ https://www.ncbi.nlm.nih.gov/pubmed/31248404 http://dx.doi.org/10.1186/s12916-019-1361-2 |
Ejemplares similares
-
Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons – results of further analyses of DIABRISK-SL in those below 18 years of age
por: Fountoulakis, Nikolaos, et al.
Publicado: (2019) -
DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial
por: Wijesuriya, Mahen, et al.
Publicado: (2011) -
Undertaking Research in Other Countries: Further Considerations
por: Muula, Adamson
Publicado: (2007) -
Further Challenges
por: Jirles, B
Publicado: (2000) -
Further Education of Medical Licentiates
por: Biswas, S. S.
Publicado: (1949)